Gastrointestinal Cancer News

United States District Judge Robert G. James for the District Court for the Western District of Louisiana issued a consent decree of permanent injunction against Pick and Pay Inc./Cili Minerals for unlawfully manufacturing and distributing unapproved new and misbranded drugs, as well as adulterated and misbranded dietary supplements, according to a press release issued by the FDA.

A majority of patients with cancer and their caregivers lack sufficient knowledge about advances in diagnostic and treatment options, according to results of a survey released by Cancer Treatment Centers of America.

Tremendous excitement currently surrounds the use of immuno-oncology agents for the treatment of various of solid tumors.

Boston Biomedical initiated a global phase 3 study that will evaluate napabucasin in combination with standard of care for treatment of metastatic pancreatic cancer.

Over the years, I have taught my residents and fellows that, if something does not make sense in clinical practice, it is probably wrong.

The prognostic impact of tumor-infiltrating lymphocytes for colorectal cancer differed based on primary tumor site, according to study results scheduled for presentation at the 2017 ASCO-SITC Clinical Immuno-Oncology Symposium.

A: First, it is important to describe what a vague hypoechoic lesion of the pancreas means to an endosonographer (Figure 1). Any lesion that is large, well circumscribed, cystic, or distorts surrounding structures (main or side branch ducts, vessels, etc.) does not fall into this category. The differential diagnosis of a vague hypoechoic lesion of the pancreas includes normal changes, chronic pancreatitis (including focal), lobularity (normal parenchyma surrounded by fibrous bands), and, much less likely, a neuroendocrine tumor, lymphoma, metastatic tumor, or early cancer. The two main factors to consider in managing these vague hypoechoic lesions of the pancreas found on endoscopic ultrasound (EUS) are the pretest probability of a neoplastic lesion and the risk of fine needle aspiration (FNA) itself.

The NIH awarded an $8.8 million grant to Huntsman Cancer Institute at University of Utah to expand research into how lifestyle and other factors affect colon cancer outcomes.

Nearly one-third of nonelderly Americans recently diagnosed with cancer change their prescription drug use for financial reasons, according to an analysis published in Cancer.

Two of the most widely used genetic sequencing tests — FoundationOne and Guardant360 — showed “widely discordant” results in the same patients, according to a small online study published in JAMA Oncology.